Cognition Disorders Clinical Trial
— SOCCEROfficial title:
Rehabilitation of Social Cognition in Subjects With Traumatic Brain Injury. Efficiency of a Computer Rehabilitation Treatment
Verified date | February 2020 |
Source | Institut Guttmann |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In the present study the investigators aim to analyze the performance in a battery of social
cognition tests of subjects with traumatic brain injury.
On the other hand, the effectiveness of a computerized rehabilitation program designed to
improve these deficits will be tested, as well as the relationship between social cognition
and executive functioning.
Status | Active, not recruiting |
Enrollment | 45 |
Est. completion date | January 2, 2022 |
Est. primary completion date | January 2, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age at the time of the TBI equal to or greater than 18 years. - Evolution time between the TBI and the beginning of the participation in the study less than 6 months. - Find out from the Post-Traumatic Amnesia Phase, evaluated through the Galveston Orientation and Amnesia Test (GOAT) scale: it is considered that the patient is out of PTA if he obtains scores greater than 75 in two consecutive administrations. - Cognitive impairment through the neuropsychological scan battery that is administered by clinical protocol. Exclusion Criteria: - Alteration of the language that compromises the complete application of the neuropsychological exploration battery. - Psychiatric history or neurological involvement prior to TBI. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital de Neurorehabilitació Institut Guttmann | Badalona | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Institut Guttmann |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | International Affect Picture System (IAPS) | Designed to provide a standardized set of pictures for studying emotion and attention. This subtest has a puntuation range from 0 to 25, where higher values are considered to be a better outcome. | 1 day | |
Primary | Pictures of facial Affect (POFA) | It is an assessment test of the ability to identify basic emotions in facial. This subtest has a puntuation range from 0 to 65, where higher values are considered to be a better outcome. expressions | 1 day | |
Primary | The Moving Shapes Paradigm | Evaluation of the interaction between two triangles based on low level. This subtest has a puntuation range from 0 to 12, where higher values are considered to be a better outcome. inferences | 1 day | |
Primary | Reading The Mind in the Eyes Test (RMET) | Advanced test of theory of mind. The subject must identify emotions in the eyes of photographed people. This subtest has a puntuation range from 0 to 36, where higher values are considered to be a better outcome. | 1 day | |
Primary | Social Decision Making Task The Social Decision Making Task (SDMT) | Pseudo online test of catch and throw where the participant is required to use social feedback. | 1 day | |
Secondary | Conners Continuous Performance Test (CPT-II) | To improve performance in sustained attention after receiving experimental intervention. Puntuation range from 0 to 100. The correct puntuation ranges from 40 to 60. | 1 day | |
Secondary | Rey Auditory Verbal Learning Test (RAVLT) | To improve performance in short-term, long-term and recognition. This test has puntuation range from 0 to 75. | 1 day | |
Secondary | Spanish phonemic fluency test- PMR | To improve performance in phonemic fluency after receiving experimental intervention. This subtest has a puntuation range from 0 to 100, where higher values are considered to be a better outcome. | 1 day | |
Secondary | Digit Span forward Subtest from the Wechsler Adult Intelligence Scale (WAIS-III) | To improve performance in span of immediate verbal recall after receiving experimental intervention. This subtest has a puntuation range from 2 to 9, where higher values are considered to be a better outcome. | 1 day | |
Secondary | Digit Span backward Subtest from the Wechsler Adult Intelligence Scale (WAIS-III) | To improve performance in working memory after receiving experimental intervention. This subtest has a puntuation range from 2 to 8, where higher values are considered to be a better outcome. | 1 day | |
Secondary | Letter-Number Sequencing Subtest from the Wechsler Adult Intelligence Scale (WAIS-III) | To improve performance in working memory after receiving experimental intervention. This subtest has a puntation range from 1 to 21, where higher values are considered to be a better outcome. | 1 day | |
Secondary | Digit Symbol-Coding Subtest from the Wechsler Adult Intelligence Scale (WAIS-III) | To improve performance in speed of processing. This subtest has a puntuation range from 1 to 133, where higher values are considered to be a better outcome. | 1 day | |
Secondary | Block Design Subtest from the Wechsler Adult Intelligence Scale (WAIS-III) | To improve performance in visuoconstruction and planning. This subtest has a puntuation range from 1 to 68, where higher values are considered to be a better outcome. | 1 day | |
Secondary | Stroop Color and Word test (Stroop Test) | To improve performance in inhibitory control. This subtest has a puntuation range from 1 to 100, where higher values are considered to be a better outcome. | 1 day | |
Secondary | Trail Making Test A (TMT-A) | To improve performance in visual attention. This subtest has a puntuation range from 1 to 999 seconds, where higher values are considered to be a worst outcome. | 1 day | |
Secondary | Trail Making Test B (TMT-B) | To improve performance in task-switching. This subtest has a puntuation range from 1 to 999 seconds, where higher values are considered to be a worst outcome. | 1 day | |
Secondary | Wisconsin Card Sorting Test (WCST) | To improve performance in cognitive flexibility. This subtest has a puntuation range from 1 to 6 categories, where higher values are considered to be a better outcome. | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02488720 -
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
|
||
Recruiting |
NCT03544801 -
Renji Cerebral Small Vessel Disease Corhort Study
|
||
Recruiting |
NCT02813434 -
Cerebral Amyloid Imaging Using Florbetapir (AV-45)
|
Phase 3 | |
Completed |
NCT00400790 -
Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane
|
N/A | |
Completed |
NCT00052091 -
Therapy for Depressed Elders With Thought Problems
|
Phase 3 | |
Completed |
NCT00021866 -
Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
|
N/A | |
Completed |
NCT00267163 -
Brain Imaging and Mental Disorders of Aging Intervention
|
Phase 4 | |
Not yet recruiting |
NCT04079075 -
Multiple Interventions to Prevent Cognitive Decline
|
N/A | |
Terminated |
NCT03696082 -
A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines
|
N/A | |
Completed |
NCT02918539 -
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
|
||
Active, not recruiting |
NCT01708837 -
Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction
|
Phase 4 | |
Completed |
NCT01290939 -
Bevacizumab and Lomustine for Recurrent GBM
|
Phase 3 | |
Terminated |
NCT00548327 -
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
|
Phase 2 | |
Unknown status |
NCT00256425 -
Cognitive Rehabilitation of Glioma Patients
|
Phase 3 | |
Recruiting |
NCT03926351 -
High Dose Omega 3 in People at Risk for Dementia
|
Phase 2 | |
Completed |
NCT02118571 -
Schizophrenia Cognition Scale Development
|
N/A | |
Completed |
NCT01481961 -
Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease
|
N/A | |
Completed |
NCT00788918 -
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
|
N/A | |
Completed |
NCT00564902 -
The Zeaxanthin and Visual Function Study
|
N/A | |
Completed |
NCT00529581 -
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
|
Phase 2 |